Cleared Traditional

K062222 - UNITIP HIGH RESOLUTION CATHETER

K062222 is an FDA 510(k) clearance for UNITIP HIGH RESOLUTION CATHETER, manufactured by Unisensor AG. The device is a Class 2 Gastroenterology & Urology device with product code FFX cleared through the Traditional 510(k) pathway after a 225-day FDA review.

K062222 · Unisensor AG · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2007
Decision
225d
Days
Class 2
Risk

K062222 is an FDA 510(k) clearance for the UNITIP HIGH RESOLUTION CATHETER. Classified as System, Gastrointestinal Motility (electrical) (product code FFX), Class II - Special Controls.

Submitted by Unisensor AG (Golden, US). The FDA issued a Cleared decision on March 15, 2007 after a review of 225 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1725 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Unisensor AG devices

FDA 510(k) Submission Details - K062222

510(k) Number K062222 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2006
Decision Date March 15, 2007
Days to Decision 225 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 131d · This submission: 225d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FFX Device Classification - Class 2, Special Controls

Product Code FFX System, Gastrointestinal Motility (electrical)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FFX System, Gastrointestinal Motility (electrical)

All 52
Devices cleared under the same product code (FFX) and FDA review panel - the closest regulatory comparables to K062222.
MANOSCAN MOTILITY WITH IMPEDANCE VISUALIZATION SYSTEM
K091070 · Sierra Scientific Instruments, Inc. · May 2009
ANORECTAL MANOMETRY SOFTWARE OPTION ARM-1
K082056 · Life-Tech, Inc. · Nov 2008
MODIFICATION TO SOLAR GI
K071094 · Medical Measurement Systems B.V. · Aug 2007
OHMEGA
K060166 · Medical Measurement Systems B.V. · Apr 2006
SOLAR GI
K052338 · Medical Measurement Systems B.V. · Dec 2005
INSIGHT, MODEL S980000
K012232 · Sandhill Scientific, Inc. · Jun 2002